
Formalin-fixed and paraffin embedded human brain glioma labeled with Anti-DEPDC1B Polyclonal Antibody, Unconjugated (bs-14278R) at 1:500 followed by conjugation to the secondary antibody and DAB staining.
DEPDC1B/BRCC3 Polyclonal Antibody
BS-14278R
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetDEPDC1B
Overview
- SupplierBioss
- Product NameDEPDC1B/BRCC3 Polyclonal Antibody
- Delivery Days Customer16
- ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
- Applications SupplierWB(1:300-5000), ELISA(1:500-1000), IHC-P(1:200-400), IHC-F(1:100-500), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 ug/ul
- ConjugateUnconjugated
- Gene ID55789
- Target nameDEPDC1B
- Target descriptionDEP domain containing 1B
- Target synonymsBRCC3, XTP1, DEP domain-containing protein 1B, HBV X-transactivated gene 8 protein, HBV XAg-transactivated protein 8, HBxAg transactivated protein 1, breast cancer cell 3
- HostRabbit
- IsotypeIgG
- Protein IDQ8WUY9
- Protein NameDEP domain-containing protein 1B
- Storage Instruction-20°C
- UNSPSC12352203
References
- Ma X, Du T, Zhu D, et al. High levels of glioma tumor suppressor candidate region gene 1 predicts a poor prognosis for prostate cancer. Oncol Lett. 2018,16(5):6749-6755. doi: 10.3892/ol.2018.9490Read this paper
- Bai S, Chen T, Du T, et al. High levels of DEPDC1B predict shorter biochemical recurrence-free survival of patients with prostate cancer. Oncol Lett. 2017,14(6):6801-6808. doi: 10.3892/ol.2017.7027Read this paper





